Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Latigo Biotherapeutics, Inc.

Latigo Biotherapeutics, Inc.

Stage unknownThousand Oaks, CABiotechnology
Facts
Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
2
Financing history
1 rounds
  1. Jan 28, 2025
    Form D equity offering · $50.0M (form d sold) · 7 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Latigo Biotherapeutics, Inc. filed Form D: $49,999,995 sold of $149,999,990, Biotechnology”
Investors on record
2 edges
People
2 officers, 6 directors
Timeline
1
  1. Feb 13, 2025
    Latigo Biotherapeutics, Inc. filed Form D: $49,999,995 sold of $149,999,990, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
16 observations
Every observation on this company